Navigation Links
Objective in Biological Technology

Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting

... Endpoint Data from Phase II Study Shows 71% objective Tumor Response Rate in Evaluable Patients ... in the first cohort of the trial achieved an objective tumor response by the end of the treatment period ... cancer study later this year." The primary objective of this multi-center, open-label Phase II study ...

Peregrine Pharmaceuticals Reports Positive Data in Second Phase II Bavituximab Breast Cancer Trial

... with Carboplatin + Paclitaxel Achieved an objective Tumor Response - - Patient Dosing Underway ... patients in the initial cohort achieved an objective tumor response after a maximum of six treatment ... "We are pleased to see these additional objective tumor responses in these advanced breast cancer ...

BioVex Commences OncoVEX (GM-CSF) Phase 3 Trial in Metastatic Melanoma

... The trial was designed to measure overall objective response, which is defined as a complete response ... progressing after having failed prior therapy. 13 objective systemic responses (26% objective response rate) were achieved including eight CRs, ...

BioVex Raises $40 Million in First Close of Series F Financing

... will also be response rate-based; the primary objective being to demonstrate a statistically significant increase in the rate of objective responses maintained for six months or more, in ... The trial was designed to measure overall objective response, which is defined as a complete response ...

Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer

... the Trial's First Stage Achieved objective Tumor Responses- -Patient Enrollment is ... evaluable breast cancer patients achieved an objective tumor response according to RECIST criteria. ... important, hard-to-treat disease." The main objective of the multi-center, open label Phase II study is ...

Oncolytics Biotech Inc. Announces 2008 Second Quarter Results

... no curative standard therapy exists. The primary objective of the Phase II trial is to measure tumour ... evidence of antitumour activity. The secondary objective is to determine the safety and tolerability of ... no curative standard therapy exists. The primary objective of the Phase II trial is to measure tumour ...

Peregrine Pharmaceuticals Presents Promising Phase I Data at ASCO and Provides Clinical Update on Its Phase II Bavituximab Breast Cancer Study

... of Bavituximab Plus Chemotherapy Achieved objective Tumor Response or Stable ... Phase II Breast Cancer Study Showing objective Tumor Response or Stable Disease - CHICAGO and ... half of evaluable patients in the trial achieved objective tumor response or stable disease after eight ...

Transgene in 2007: Partnership and Refinancing Position the Company for its Future Development

... and intends to expand its clinical portfolio. Our objective is to move one new product candidate into ... in France, Switzerland and the United States. The objective was the recruitment of 41 patients suffering from ... for mixed usage (laboratories and offices). The objective is to optimize our R&D resources through ...

Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease

... Summary of Study Results: The primary objective of the Phase 2 trials was to evaluate the ... of treatment with Amigal. The secondary objective was to evaluate certain pharmacodynamic measures ... affected by the disease. An additional objective was the preliminary assessment of cardiac and ...

Oncolytics Biotech Inc. Announces 2007 Third Quarter Results

... unaffected by cellular irradiation. The primary objective of the Phase Ia/Ib trial was to determine ... radiation treatment. A secondary objective is to examine any evidence of anti-tumour ... no curative standard therapy exists. The primary objective of the trial is to determine the MTD, DLT, ...

Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses

... in 46 healthy volunteers. The primary objective of Part 1 is to assess the safety, ... doses under fasting conditions. The secondary objective of Part 1 is to explore the effect of food ... failed interferon therapy. The primary objective of Part 2 is to assess the safety, ...

Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) CII Provided Significant Improvement of ADHD Symptoms for Children at 13 Hours After Administration

... and their optimal dose of Vyvanse the second week. The primary objective of this study was to assess the time of onset of Vyvanse compared with ... efficacy as measured by both subjective (SKAMP-D and SKAMP-A) and objective (PERMP) assessments from the first time point (1.5 hours) through the last ...

FDA Approves Labeling Change for VYVANSE(R) (lisdexamfetamine dimesylate) CII to Include Supplementary Clinical Data Supporting Efficacy at 13 Hours Postdose in Children Aged 6 to 12 with ADHD

... week and their optimal dose of VYVANSE the second week. The primary objective of this study was to assess the time of onset of VYVANSE compared with ... efficacy as measured by both subjective (SKAMP-D and SKAMP-A) and objective (PERMP) assessments from the first time point (1.5 hours) through the last ...

OncoGenex Pharmaceuticals Announces OGX-011 Treatment Provides Survival Benefit in Randomized Phase 2 Trial in Advanced Metastatic Prostate Cancer

... with OGX-011 plus docetaxel. Secondary endpoints included determining objective response and duration of response in those patients with measurable ... discontinued trial treatment early for PSA progression and/or objective disease progression compared to the docetaxel arm (16 patients). ...

DFG establishes 14 new research training groups

... own that could serve as the basis for an independent project proposal. The objective of this measure is to encourage promising researchers to pursue a career ... of mass and structure of materials is as much a part of the scientific objective as is the topic of extending the previous standard model. (Host ...

Oncolytics Biotech(R) Inc. Announces Positive Results of U.K. Phase II REOLYSIN(R) and Radiation Combination Clinical Trial

... positive results in its U.K. Phase II clinical trial to evaluate the objective tumour response rate of REOLYSIN(R) in combination with low-dose radiation ... (1x10(10) TCID(50)) on days two and four. The primary endpoint was objective tumour response rate in treated lesions. Secondary endpoints were to ...

Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma

... a first-line treatment for patients with mesothelioma. The primary objective of the study is to assess the efficacy of MORAb-009 as combination therapy ... include safety and anti-tumor activity of MORAb-009 as determined by objective response rate. The patient population includes individuals with locally ...

New Study Reports Improved Patient Outcomes for Breast Cancer Patients

... of pathology at Henry Mayo and lead author of the study, the first objective of the study was to evaluate the factors known to influence outcomes. ... therapy and/or chemotherapy/hormonal treatment," she says. "The second objective was to evaluate the percentage of cases in which the initial ...

Air Products and Alter NRG Sign JDA on Renewable Energy Projects

... energy production. This agreement will help Air Products move towards its objective of providing sustainable energy by turning renewable feedstock into an ... sustainable and economically viable gasification projects. The Company's objective is to further commercialize the Westinghouse Plasma technology, a wholly ...

Peregrine Pharmaceuticals' Bavituximab Achieves Primary Endpoint in First Stage of Phase II Lung Cancer Study

... -Preliminary Data Show Seven of 17 Evaluable Patients Achieved an objective Tumor Response by End of Four Treatment Cycles- TUSTIN, Calif., Feb. ... this study as patient treatment and follow-up progress." The primary objective of the multi-center Phase II clinical trial in patients with previously ...

Results From Phase 2 Clinical Study of 6R-BH4 in Peripheral Arterial Disease Not Statistically Significant

... co-administered Vitamin C at 500 mg/day twice daily. The primary objective of the study was to evaluate mean change in peak walking time from baseline to week 24. The secondary objective of the study was to evaluate the mean change in claudication onset time ...

Sirius Genomics Announces New Collaboration with UK Critical Care Genomics Group

... "The collaboration with Sirius Genomics is in direct alignment with our objective to disseminate and promote understanding of functional genomics in the ... United Kingdom representing more than 35 hospitals. The group's primary objective is to undertake clinical functional genomics research in the critically ...

bwin and Harvard Medical School Faculty Sign 5-Year Research Cooperation Agreement

... an agreement for research collaboration for five years. The research objective is to use scientific evidence to create the safest possible online gaming ... research has just been extended for another five years. The prime research objective is to establish a scientific evidence base that can guide the development ...

New Clinical Studies Presented at the American Society of Anesthesiology (ASA) Annual Meeting Show Masimo Technologies Provide Advanced Clinical Intelligence

... Low Perfusion pulse oximetry, announced today that 13 new independent and objective clinical studies presented at the American Society of Anesthesiology (ASA) ... ability to detect life-threatening events. More than 100 independent and objective studies demonstrate Masimo SET provides the most reliable SpO2 and pulse ...

Five New Clinical Studies Show Value of Masimo PVI & PI

... pulse oximetry, announced today that five new independent and objective studies demonstrating Masimo PVI to be highly predictive of patient fluid ... ability to detect life-threatening events. More than 100 independent and objective studies demonstrate Masimo SET provides the most reliable SpO2 and pulse ...

Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin

... therapy or for which no curative standard therapy exists. The primary objective of the Phase 2 trial is to measure tumour responses and duration of response, and to describe any evidence of antitumour activity. The secondary objective is to determine the safety and tolerability of REOLYSIN(R) when ...

Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008

... having any tumor growth to date and half of the patients achieving an objective tumor response by the first eight-week evaluation point. These are ... trial designed to evaluate its safety and efficacy. The study's primary objective is to confirm the maximum tolerated dose of Cotara and secondary ...

Oncolytics Biotech Inc. Announces U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin

... therapy or for which no curative standard therapy exists. The primary objective of the Phase 2 trial is to measure tumour responses and duration of response, and to describe any evidence of antitumour activity. The secondary objective is to determine the safety and tolerability of REOLYSIN(R) when ...

Oncolytics Biotech Inc. Announces Start of Enrolment in Phase 1/2 Ovarian Cancer Clinical Trial with REOLYSIN(R)

... IP REOLYSIN(R) when used with a fixed dose of IV REOLYSIN(R). The primary objective of the Phase 2 trial is to determine the objective response rate of treatment with IV and IP REOLYSIN(R) in patients with ...

Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin

... therapy or for which no curative standard therapy exists. The primary objective of the Phase II trial is to measure tumour responses and duration of response, and to describe any evidence of antitumour activity. The secondary objective is to determine the safety and tolerability of REOLYSIN(R) when ...

Quest PharmaTech Announces Positive Results from Phase I Clinical Trial of its Photodynamic Therapy for Actinic Keratosis

... treatment of Actinic Keratosis to be about US $250 million. The primary objective of the Phase I study, which was conducted in Canada, was to determine the ... photoactive drug, SL017, with and without photoactivation. The exploratory objective was to evaluate the efficacy of SL017 with and without photoactivation in ...

Pharmaxis' Aridol Authorised for Sale in Germany

... in people with conditions such as asthma. "The Aridol test provides objective information on airway hyperresponsiveness and assists in the diagnosis and ... may be receiving inappropriate medication because of the absence of an objective test -- until now. Clinical trial results suggest that 25% of asthmatic ...

Oncolytics Biotech Inc. Announces U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin

... therapy or for which no curative standard therapy exists. The primary objective of the Phase II trial is to measure tumour responses and duration of response, and to describe any evidence of antitumour activity. The secondary objective is to determine the safety and tolerability of REOLYSIN(R) when ...

Oral PBI-1402 Demonstrates Significant Activity in Chemotherapy-Induced Anemia Phase II Clinical Trial

... the Oncologic Drugs Advisory Committee emphasizes that the primary objective of treating CIA patients with erythropoiesis-stimulating agents ("ESAs") ... RBC transfusions. "These results are very exciting and meet the primary objective that formed the basis for FDA approval of other ESAs in CIA patients," ...

Victhom announces promising results on the proof of concept for its unique closed-loop neuromodulation system

... clinical trial on the Neurostep(TM) has two major objectives. The first objective is to evaluate the sensing and stimulation mechanisms of the product. The ... Company expects to announce later this year results on the second major objective of the trial aimed at evaluating the efficacy of the Neurostep (TM) in ...

Neptune Technologies & Bioressources Inc. reports third quarter results and update on strategic milestones

... food stores and healthcare professionals with the short-term marketing objective of reaching 3,000 pharmacies. Additional products launches are expected in ... its business strategy, negotiations with pharmaceutical companies with the objective of entering the pharmaceutical market by licensing rights are ongoing. ...

Aridol(TM) Endorsed by International Olympic Committee

... diagnosis of asthma in an athlete and clinical examination may be normal, objective tests are required to confirm the diagnosis. These tests would include ... may be receiving inappropriate medication because of the absence of an objective test - until now. Clinical trial results suggest that 25% of asthmatic ...

Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide

... pulse oximetry technology -- Masimo SET. More than 100 independent and objective studies demonstrate that Masimo SET provides the most trustworthy SpO2 and ... ability to detect life-threatening events. More than 100 independent and objective studies demonstrate Masimo SET provides the most trustworthy SpO2 and ...

Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease

... of patients. Phase 2 Plicera data presented at ACMG The primary objective of this study was to evaluate safety and tolerability of different doses and dosing regimens of Plicera. The secondary objective was to evaluate certain pharmacodynamic measures of treatment, including ...

Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer

... with chemotherapy in patients with advanced breast cancer. The primary objective of the study is to assess the overall response rate to the combination of ... alone and showed positive signs of clinical activity, achieving objective response or disease stabilization in 50% of the evaluable patients. ...
Other Contents
(Date:12/11/2014)... , Dec. 10, 2014  Data Sciences International ... has released a new series of digital telemetry ... toxicology researchers. M series, part of the PhysioTel™ ... the best possible physiologic data when incorporating functional ... functional endpoints to toxicology studies has evolved from ...
(Date:12/10/2014)... Dec. 9, 2014  Wake Forest Baptist Medical Center today ... its School of Medicine. Funding for this $50 million ... that will be publicly launched next summer. ... the former 60 series R.J. Reynolds Tobacco Company complex, ... will begin immediately with plans to be ready to ...
(Date:12/10/2014)... , December 9, 2014 ... ITN,s BCARD Platform   ... enterprise meeting scheduling solutions for business-to-business (B2B) events, ... world leader in mobile near-field communication (NFC), Bluetooth ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow ...
Breaking Biology News(10 mins):New telemetry implants expected to change how large animal toxicology studies are conducted 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3
(Date:12/25/2014)... The microscopy market is estimated ... reach $5,756.0 million by 2019. Optical microscopy is ... electron microscopes product segment is expected to show ... Rising focus on nanotechnology, technological advancements, and increasing ... market. , Get Full Copy of Report @ ...
(Date:12/25/2014)... TX (PRWEB) December 26, 2014 ... Market Analysis to 2023” focuses on the current ... opportunities in the colorectal cancer market. Stivarga is ... of colon or rectal cancer. Boehringer Ingelheim is ... for the treatment of refractory CRC in the ...
(Date:12/25/2014)... three months the trends for evening dresses shift ... one of the hottest styles in the next few months.” ... releases 26 A-line sweetheart evening dresses, and announces the availability ... are trying our best to help a lady to show ... affordable prices, we provide discounted delivery costs to our customers ...
(Date:12/25/2014)... 25, 2014 The short film “Color of ... in honor of a true 9/11 hero, Welles Remy Crowther. ... including the 24 hours of Nuremberg International Short Film Festival ... , Actress, screenwriter and director Luciana Lagana plays ... together with her husband, Gregory Graham - Graham ...
(Date:12/25/2014)... December 25, 2014 Helen Harris’ RP ... Woodland Hills, California after an 8 year battle with ... Christmas Eve evening in her home in Woodland Hills ... breast cancer. , As the founder ... years, she pioneered and championed many of today's greatest ...
Breaking Medicine News(10 mins):Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4
Other TagsOther Tags